John Wilding leads Clinical Research into Obesity, Diabetes and Endocrinology at the University of Liverpool. She is the Associate Dean for Research for the Faculty of Health and Medicine and Deputy Clinical Director of the NIHR North West Coast Clinical Research Network. Her clinical work includes cardiovascular risk factor and weight management clinics. This includes interdisciplinary, mixed methods research to develop complex interventions, and pragmatic, efficient clinical trials utilising health record data. Her work focuses on interventions at the level of the individual with the aim of treating or preventing the complications of obesity. Jennifer Logue is Professor and Honorary Consultant in Metabolic Medicine, focusing both her research and clinical practice on the treatment of obesity and related metabolic disease.
ABCD 2 ONLINE PROFESSIONAL
Current research work ranges from studies on novel endoscopic based treatments for type 2 diabetes to the use of large datasets to understand the clinical course of diabetes and improving the understanding of the experience living with diabetes.ĭavid has been actively engaged in multidisciplinary health professional education throughout his career and is leading on a new King’s College London online Masters level programme which will launch in 2021. He is Co-Chair of the Council of Healthcare Professionals at Diabetes UK and is a former member of the UK DAFNE collaborative executive.ĭavid has broad clinical and academic interests across the whole spectrum of diabetes and runs specialist clinics for advanced type 1 diabetes management islet and pancreas transplantation and diabetes complication management. He is Director of the Institute of Diabetes, Endocrinology and Obesity at King’s Health Partners, an academic health science centre comprising King’s College London, King’s College Hospital, Guy’s & St Thomas’ Hospitals and South London & Maudsley NHS trust. She has served as Treasurer of the Society for Endocrinology and as a Trustee of the Association for the Study of Obesity.ĭavid Hopkins is a consultant physician and diabetologist based in London. She chairs the GIRFT/ABCD Obesity Task Force. Professor McGowan is a SCOPE National fellow, a member of the European Society for Endocrinology Policy and Advocacy Task Force and a member of the RCP Advisory Group on Weight and Health. She is an investigator for several obesity clinical trials and was awarded an NIHR/RCP/CRN prize in recognition of outstanding research within the NHS. Her areas of research interest are in gut hormones and appetite control, pharmacotherapy for obesity and remission of type 2 diabetes post-bariatric surgery. She leads the obesity bariatric service at GSTT where she manages patients with severe and complex obesity. She is R&D lead for Diabetes and Endocrinology at GSTT and the South London Specialty lead for the Metabolic and Endocrine research network. She was awarded a PhD from Imperial College London for investigating ‘The role of relaxin-3 on energy homeostasis and the hypothalamic-pituitary-axis’ and the role of gut hormones and other neuropeptides in appetite control. Professor Barbara McGowan is a Consultant Endocrinologist at Guy's and St Thomas' Hospital (GSTT) and Professor in Diabetes and Endocrinology at King’s College London. The specialist interests of his research Group are the mechanisms of action of interventions for obesity, focusing on pharmacotherapy, medical devices and obesity surgery.
He has contributed to the clinical management and research in Obesity over the last 10 years, through his work at a high throughput Obesity Centre.
His clinical and research work focus solely on Obesity.
ABCD 2 ONLINE FULL
Novo Nordisk has had no influence on the content and full editorial control remains the sole responsibility of ABCD.Īlex Miras is a Senior Lecturer and Consultant in Endocrinology and Obesity Medicine at Imperial College London. Novo Nordisk has provided sponsorship to the Association of British Clinical Diabetologists (ABCD) to fully fund all costs for the development and delivery of this webinar, including creation, administration, promotion and speaker honoraria.
The webinar will also explore how the introduction of obesity pharmacotherapy could serve as an impetus to improve the care given to patients. In this webinar Alex Miras and an expert panel will discuss the optimal ways that obesity care should be provided in the UK based on experiences with the tiered system. How will recent developments in obesity management change obesity services